Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP428947.RA6Z7RQ-h2cLfH7JwtZ9erKGn9WI8OmX_e3mf5Da42bQ4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP428947.RA6Z7RQ-h2cLfH7JwtZ9erKGn9WI8OmX_e3mf5Da42bQ4130_assertion type Assertion NP428947.RA6Z7RQ-h2cLfH7JwtZ9erKGn9WI8OmX_e3mf5Da42bQ4130_head.
- NP428947.RA6Z7RQ-h2cLfH7JwtZ9erKGn9WI8OmX_e3mf5Da42bQ4130_assertion description "[CTCs were HER-2/neu positive in six out of 11 (54%) patients with metastatic disease and in three out of 31 (9.6%) patients with localised PC (P=0.004).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428947.RA6Z7RQ-h2cLfH7JwtZ9erKGn9WI8OmX_e3mf5Da42bQ4130_provenance.
- NP428947.RA6Z7RQ-h2cLfH7JwtZ9erKGn9WI8OmX_e3mf5Da42bQ4130_assertion evidence source_evidence_literature NP428947.RA6Z7RQ-h2cLfH7JwtZ9erKGn9WI8OmX_e3mf5Da42bQ4130_provenance.
- NP428947.RA6Z7RQ-h2cLfH7JwtZ9erKGn9WI8OmX_e3mf5Da42bQ4130_assertion SIO_000772 14735191 NP428947.RA6Z7RQ-h2cLfH7JwtZ9erKGn9WI8OmX_e3mf5Da42bQ4130_provenance.
- NP428947.RA6Z7RQ-h2cLfH7JwtZ9erKGn9WI8OmX_e3mf5Da42bQ4130_assertion wasDerivedFrom befree-2016 NP428947.RA6Z7RQ-h2cLfH7JwtZ9erKGn9WI8OmX_e3mf5Da42bQ4130_provenance.
- NP428947.RA6Z7RQ-h2cLfH7JwtZ9erKGn9WI8OmX_e3mf5Da42bQ4130_assertion wasGeneratedBy ECO_0000203 NP428947.RA6Z7RQ-h2cLfH7JwtZ9erKGn9WI8OmX_e3mf5Da42bQ4130_provenance.